Skip to main content
. 2021 May 14;42(6):103080. doi: 10.1016/j.amjoto.2021.103080

Table 2.

Risk factors of the studied AIFRS patients.

Risk factors
Males
Females
Total
2017 No. % No. % N = 9 %
Diabetes mellitus 3 50.0 3 50.0 6 66.7
Immunosuppressive drugs 0 0.00 2 100 2 22.2
Liver cell failure 0 0.00 1 100 1 11.1



Risk factors
Males
Females
Total
2018 No. % No. % N = 8 %
Diabetes mellitus 4 50.0 4 50.0 8 100
Liver cell failure 2 100 0 0.00 2 25.0
Renal failure 1 100 0 0.00 1 12.5



Risk factors
Males
Females
Total
2019 No. % No. % N = 10 %
Diabetes mellitus 2 28.57 5 71.43 7 70.0
Immunosuppressive drugs 0 0.00 1 100 1 10.0
Liver cell failure 2 66.7 1 33.3 3 30.0
Leukemia 1 100 0 0.00 1 10.0



Risk factors
Males
Females
Total
2020 No. % No. % N = 29 %
Diabetes mellitus 5 62.5 3 37.5 8 27.6
Renal failure 1 100 0 0.00 1 3.45
Liver cell failure 1 100 0 0.00 1 3.45
Immunosuppressive drugs 0 0.00 1 100 1 3.45
Post-COVID-19 12 66.67 6 33.33 18 62.1